Search results
Got $500? 3 Pharma Stocks to Buy and Hold Forever | The Motley Fool
The Motley Fool· 1 hour agoWith that in mind, let's examine three leading pharma stocks that are ripe for buying today and...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 6 days agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 4 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Pfizer shares the ADC data that convinced it to start a Phase 3 lung cancer trial
Endpoints News· 3 days agoWhen Pfizer laid out the ambitious vision for its new oncology division in February, it announced...
Is Pfizer Finally Seeing Light at the End of the Tunnel?
TheStreet.com· 3 days agoPharmaceutical giant Pfizer (PFE) has been a weak performer in the stock market. The shares are...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 3 days agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
Pfizer announces another $1.5B in cost cuts — and plans for more to come
Endpoints News· 4 days agoMonths after beginning a $4 billion savings strategy, Pfizer is planning on a new $1.5 billion round...
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 4 days agoThe company said it estimates savings of $1.5 billion in the plan’s first phase by the end of 2027.
HILL TAX BRIEF: Wyden Blasts Pfizer on International Tax Shifts
Bloomberg Law· 4 days agoSenate Finance Committee Chair Ron Wyden (D-Ore.) is expanding his investigation into profit-shifting practices of pharmaceutical companies with a new letter to drug powerhouse Pfizer.